TessellateBio
Drug discovery
We are a pioneering and fast-growing international biotechnology company, focusing on targets to address cancers that depend on synthetic lethality (SL) mechanisms.
We are looking to use our substantial funding to expand our innovative pipeline by exploiting additional targets for patient populations with unmet needs
See other Drug discovery organisations
-
Enedra is harnessing the power of synthetic lethality and advanced computational Systems Biology to create therapeutics. -
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor (TCR)- based cancer immunotherapies. -
GlamorousAI is AI-first preclinical biotech focusing on the discovery of novel chemistry for challenging targets. -
Human Centric Drug Discovery helps patients with central nervous disorders by making it easier to develop drugs for their diseases.
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.